1. Yang, Rui, Wang, Mei, Zhang, Guanghui, Wang, Lulin, Cui, Hongjuan. 2021. POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway. In Cell death & disease, 12, 433. doi:10.1038/s41419-021-03719-3. https://pubmed.ncbi.nlm.nih.gov/33931589/
2. Li, Jun, Li, Pei-Ting, Wu, Wei, Qian, Li-Yuan, Du, Juan. 2024. POU2F2-mediated upregulation of lncRNA PTPRG-AS1 inhibits ferroptosis in breast cancer via miR-376c-3p/SLC7A11 axis. In Epigenomics, 16, 215-231. doi:10.2217/epi-2023-0100. https://pubmed.ncbi.nlm.nih.gov/38318853/
3. Luo, Ronggang, Zhuo, Yi, Du, Quan, Xiao, Rendong. 2021. POU2F2 promotes the proliferation and motility of lung cancer cells by activating AGO1. In BMC pulmonary medicine, 21, 117. doi:10.1186/s12890-021-01476-9. https://pubmed.ncbi.nlm.nih.gov/33832481/
4. Shi, Hengchuan, Wang, Wenqing, Luo, Jun, Song, Guoxin, Han, Rongbo. 2025. POU2F2+ B cells enhance antitumor immunity and predict better survival in non small cell lung cancer. In Scientific reports, 15, 6549. doi:10.1038/s41598-025-90817-3. https://pubmed.ncbi.nlm.nih.gov/39994401/